Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 24.58 USD 2.12% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Nurix Therapeutics Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nurix Therapeutics Inc
Pre-Tax Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Nurix Therapeutics Inc
NASDAQ:NRIX
Pre-Tax Income
-$143.9m
CAGR 3-Years
-31%
CAGR 5-Years
-74%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$7.1B
CAGR 3-Years
5%
CAGR 5-Years
14%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$1.5B
CAGR 3-Years
-39%
CAGR 5-Years
-29%
CAGR 10-Years
-17%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$3.5B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$214.7m
CAGR 3-Years
-55%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$4.6B
CAGR 3-Years
-14%
CAGR 5-Years
17%
CAGR 10-Years
19%

See Also

What is Nurix Therapeutics Inc's Pre-Tax Income?
Pre-Tax Income
-143.9m USD

Based on the financial report for Nov 30, 2023, Nurix Therapeutics Inc's Pre-Tax Income amounts to -143.9m USD.

What is Nurix Therapeutics Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-74%

Over the last year, the Pre-Tax Income growth was 20%. The average annual Pre-Tax Income growth rates for Nurix Therapeutics Inc have been -31% over the past three years , -74% over the past five years .

Back to Top